GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/GI Surgery/ROGER Trial- BJS Feb.26
67

ROGER Trial- BJS Feb.26

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated February 1, 2026

The ROGER randomised clinical trial compared robotic transabdominal preperitoneal repair (rTAPP) with laparoscopic totally extraperitoneal repair (TEP) for elective primary inguinal hernia.

In this single-centre, patient- and investigator-blinded Swiss RCT, 182 patients were randomised 1:1 (mostly male, mean age ~56 years, BMI ~25 kg/m²). The primary endpoint was postoperative pain while coughing at 24 hours.

Results showed no significant difference in pain between approaches (median score 5 for TEP vs 4 for rTAPP, P = 0.431). Postoperative complication rates were also similar (11% vs 10%).

However, key differences emerged:

Operating time was significantly longer with rTAPP (80 vs 64 minutes for unilateral repairs).

Surgeon workload, measured using the NASA Task Load Index, was substantially lower with rTAPP (mean 18 vs 34, P < 0.001).

Thus, while robotic repair did not improve early postoperative pain or reduce complications, it significantly reduced perceived surgical workload—at the cost of longer operative time.

Clinical takeaway: For patients, outcomes are equivalent. For surgeons, robotics may improve ergonomics and reduce fatigue. The decision to adopt robotic repair may therefore depend more on institutional resources and surgeon factors than on short-term patient benefit.

Related Q&A

68

Delayed Leak Recognition After Colon Resection - JAMA Surgery Feb 26

Anastomotic leak remains a leading driver of morbidity and mortality after colon resection. This large Veterans Affairs Surgical Quality Improvement Program cohort study evaluated whether the timing of...

69

Molecular Residual Disease and Recurrence in Rectal Cancer- Ann. Sur Jan.26

The study titled "Molecular Residual Disease and Recurrence in Rectal Cancer" published in Annals of Surgery on January 26 explores the prognostic utility of circulating tumor DNA (ctDNA)...

70

Reevaluating Intraoperative Neck Margin Revision After Neoadjuvant Therapy in Pancreatic Cancer

The study titled "Reevaluating Intraoperative Neck Margin Revision After Neoadjuvant Therapy in Pancreatic Cancer" explores the oncologic benefits of revising a positive pancreatic neck margin during pancreatoduodenectomy (PD)...

71

Perioperative Use of Tranexamic Acid

The perioperative use of tranexamic acid (TXA) has been extensively studied in various surgical contexts, including general surgery, to evaluate its efficacy in reducing blood loss, the need...

72

Intrathecal Morphine for Enhanced Recovery After Laparoscopic Colorectal Surgery

Intrathecal Morphine (ITM) has been evaluated as a component of multimodal pain management to enhance recovery after laparoscopic colorectal surgery within the framework of Enhanced Recovery After Surgery...

73

Multi-Omics Analysis of Ileal Mucosa and Mesentery Before and After Ileocecal Resection in Crohn’s Disease

The multi-omics analysis of ileal mucosa and mesentery before and after ileocecal resection in Crohn’s disease (CD) provides valuable insights into how surgical intervention influences the disease at...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer